KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Teladoc Health (TDOC) EBITDA Margin (2016 - 2025)

Teladoc Health's EBITDA Margin history spans 12 years, with the latest figure at 3.93% for Q4 2025.

  • For Q4 2025, EBITDA Margin rose 382.0% year-over-year to 3.93%; the TTM value through Dec 2025 reached 7.77%, up 3125.0%, while the annual FY2025 figure was 7.77%, 3125.0% up from the prior year.
  • EBITDA Margin for Q4 2025 was 3.93% at Teladoc Health, up from 7.78% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 9.64% in Q1 2022 and bottomed at 1652.44% in Q4 2022.
  • The 5-year median for EBITDA Margin is 10.18% (2023), against an average of 124.94%.
  • The largest annual shift saw EBITDA Margin tumbled -164953bps in 2022 before it skyrocketed 164875bps in 2023.
  • A 5-year view of EBITDA Margin shows it stood at 2.91% in 2021, then crashed by -56650bps to 1652.44% in 2022, then surged by 100bps to 3.69% in 2023, then plummeted by -110bps to 7.76% in 2024, then soared by 49bps to 3.93% in 2025.
  • Per Business Quant, the three most recent readings for TDOC's EBITDA Margin are 3.93% (Q4 2025), 7.78% (Q3 2025), and 4.88% (Q2 2025).